Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are naïve to Omalizumab (RILECSU). Reference standards of Rilzabrutinib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Rilzabrutinib - API Standards [catalogue_number] => PA 18 1270000 [category_ids] => ,75,76,78,70,82, [chemical_name] => [weight] => 665.77 [form] => C36H40FN9O3 [cas] => 1575596-29-0 [pslug] => 1575596-29-0-rilzabrutinib-api-pa181270000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 18 1270000
CAS :
Molecular Formula : C36H40FN9O3
Molecular Weight : 665.77
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....